Polymyositis and interstitial lung disease with a favorable response to corticosteroids and methotrexate;Polimiositis y afectación pulmonar intersticial con buena respuesta a glucocorticoides y metotrexato

Archivos de Bronconeumologia

Volumn 43, Issue 11, 2007, Pages 636-639

  Hoyosa, Nieves ^a   Casanova, Álvaro ^a   Sánchez, Silvia ^a   Valenzuela, Claudia ^a   García, Asunción ^a   Girón, Rosa María ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Lung diseases, interstitial; Nonspecific interstitial pneumonia; Polymyositis

Indexed keywords

METHOTREXATE; PREDNISONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DYSPNEA; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; MUSCLE WEAKNESS; POLYMYOSITIS; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

EID: 37849042263     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13111351     Document Type: Article

References (18)

1. Mills ES, Matthews WH. Interstitial pneumonitis in dermatopolymyositis. JAMA. 1956;160:1467-70.
2. Salmeron G, Greenberg SD, Lidsky MD. Polymyositis and diffuse interstitial lung disease. A review of the pulmonary histopathologic findings. Arch Intern Med. 1981;141:1005-10.
3. Marie I, Hatron PY, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol. 1999;26:1336-43.
4. Kourakata H, Takada T, Suzuki E, Enomoto K, Saito I, Taguchi Y, et al. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia. Respirology. 1999;4:223-8.
5. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis. 1990;141:727-33.
6. American Thoracic Society (ATS)/European Respiratory Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277-304.
7. Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR. Polymyositis-dermatomyositis associated interstitial lung disease. Am J Respir Crit Care Med. 2001;164: 1182-5.
8. Mino M, Noma S, Taguchi Y, Tomii K, Kohri Y, Oida K. Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am J Roentgenol. 1997;169:83-7.
9. Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: long term follow-up CT evaluation in seven patients. Radiology. 1999;210:333-8.
10. Ikezoe J, Johkoh T, Kohno N, Takeuchi N, Ichikado K, Nakamura H. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging. 1996;11:250-9.
11. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum. 1983;26:604-11.
12. Bernstein RM, Morgan SH, Chapman J, Bunn CC, Mathews MB, Turner-Warwick M. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J. 1984;289:151-2.
13. Mok CC, To CH, Szeto ML. Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine. Scand J Rheumatol. 2003;32:181-3.
14. Shinohara T, Hidaka T, Matsuki Y, Ishizuka T, Takamizawa M, Kawakami M, et al. Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Intern Med. 1997;36:519-23.
15. Bunch TW, Worthington JW, Combs JJ, Ilstrup DM, Engel AG. Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann Intern Med. 1980;92:365-9.
16. Bunch TW. Prednisone and azathioprine for polymyositis: long-term followup. Arthritis Rheum. 1981;24:45-8.
17. Chang HK, Lee DH. Successful combination therapy of cyclosporine and methotrexate for refractory polymyositis with anti-Jo-1 antibody: a case report. J Korean Med Sci. 2003;18:131-4.
18. Ochi S, Nanki T, Takada K, Suzuki F, Komano Y, Kubota T, et al. Favorable outcomes with tracolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis. Clin Exp Rheumatol. 2005;23:707-10.